A blood sugar biomarker identifies patients with atherosclerosis and a risk of cardiovascular events

(Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)) In an article published in JACC, CNIC scientists report a method for improved ranking of cardiovascular risk in individuals without diabetes